Table 1.

Summary of results from RNAi kinase screen in primary patient samples

Diagnosis	Sensitive, n/N	Sensitive, %
AML	17/281	6
Acute lymphoblastic leukemia	9/113	8
MPN/myelodysplastic syndrome	7/145	5
Total	33/539	6

Table shows total numbers and percentage of samples sensitive to EPHB4 knockdown tabulated by type of leukemia.

MPN, myeloproliferative neoplasm.